DP13 - A Phase II Study in Patients With Primary Aldosteronism
Condition: Primary Aldosteronism Intervention: Drug: DP13 Sponsor: Damian Pharma AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2019 Category: Research Source Type: clinical trials
